Professor of Medicine, Chief of Myeloma Division & Experimental Therapeutics Program. Sylvester Comprehensive Cancer Center, University of Miami. Tweets = mine
Sep 3, 2023 • 18 tweets • 3 min read
In collaboration with @MSKCancerCenter, @fredhutch, @NCI, @pmcancercentre, @TischCancer & @DanaFarber we are thrilled to share our recent @NatureComms paper: "Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma" (1/n)rdcu.be/dkZWW
In this tweetorial, we delve into a groundbreaking study on multiple myeloma and the immune microenvironment. Let's explore how the immune system impacts long-term treatment response in multiple myeloma (2/n)
Links to the full abstract. As in the past, I focus on scientific innovation and clinical high-impact studies. @SylvesterCancer#mmsm@mtmdphd
Thread with countdown
👇
1) Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study. ash.confex.com/ash/2021/webpr…
A game changer for the field, addressing the role of population screening. #ASH21@SylvesterCancer#mmsm@mtmdphd